Literature DB >> 28770390

Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Xiaoyun Guo1,2, Wenying Qiu3, Rolando Garcia-Milian4, Xiandong Lin5, Yong Zhang6, Yuping Cao7, Yunlong Tan8, Zhiren Wang8, Jing Shi8, Jijun Wang1, Dengtang Liu1, Lisheng Song1, Yifeng Xu1, Xiaoping Wang9, Na Liu10, Tao Sun11, Jianming Zheng11, Justine Luo2, Huihao Zhang12, Jianying Xu13, Longli Kang14, Chao Ma3, Kesheng Wang15, Xingguang Luo16,17.   

Abstract

Genome-wide association studies (GWASs) have reported numerous associations between risk variants and Alzheimer's disease (AD). However, these associations do not necessarily indicate a causal relationship. If the risk variants can be demonstrated to be biologically functional, the possibility of a causal relationship would be increased. In this article, we reviewed all of the published GWASs to extract the genome-wide significant (p < 5×10-8) and replicated associations between risk variants and AD or AD-biomarkers. The regulatory effects of these risk variants on the expression of a novel class of non-coding RNAs (piRNAs) and protein-coding RNAs (mRNAs), the alteration of proteins caused by these variants, the associations between AD and these variants in our own sample, the expression of piRNAs, mRNAs and proteins in human brains targeted by these variants, the expression correlations between the risk genes and APOE, the pathways and networks that the risk genes belonged to, and the possible long non-coding RNAs (LncRNAs) that might regulate the risk genes were analyzed, to investigate the potential biological functions of the risk variants and explore the potential mechanisms underlying the SNP-AD associations. We found replicated and significant associations for AD or AD-biomarkers, surprisingly, only at 17 SNPs located in 11 genes/snRNAs/LncRNAs in eight genomic regions. Most of these 17 SNPs enriched some AD-related pathways or networks, and were potentially functional in regulating piRNAs and mRNAs; some SNPs were associated with AD in our sample, and some SNPs altered protein structures. Most of the protein-coding genes regulated by the risk SNPs were expressed in human brain and correlated with APOE expression. We conclude that these variants were most robust risk markers for AD, and their contributions to AD risk was likely to be causal. As expected, APOE and the lipoprotein metabolism pathway possess the highest weight among these contributions.

Entities:  

Keywords:  APOE; Alzheimer’s disease; GWAS; Gene expression; Genome-wide significant; Replicated; Risk variant

Mesh:

Substances:

Year:  2017        PMID: 28770390      PMCID: PMC5654670          DOI: 10.1007/s00702-017-1773-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  70 in total

1.  Genome-wide association analysis of age-at-onset in Alzheimer's disease.

Authors:  M I Kamboh; M M Barmada; F Y Demirci; R L Minster; M M Carrasquillo; V S Pankratz; S G Younkin; A J Saykin; R A Sweet; E Feingold; S T DeKosky; O L Lopez
Journal:  Mol Psychiatry       Date:  2011-10-18       Impact factor: 15.992

2.  CSF Biomarkers for Alzheimer's Disease Diagnosis.

Authors:  A Anoop; Pradeep K Singh; Reeba S Jacob; Samir K Maji
Journal:  Int J Alzheimers Dis       Date:  2010-06-23

3.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

4.  Sorl1 as an Alzheimer's disease predisposition gene?

Authors:  Jennifer A Webster; Amanda J Myers; John V Pearson; David W Craig; Diane Hu-Lince; Keith D Coon; Victoria L Zismann; Thomas Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Matthew J Huentelman; Keta Joshipura; Douglas Walker; Christopher B Heward; Rivka Ravid; Joseph Rogers; Andreas Papassotiropoulos; John Hardy; Eric M Reiman; Dietrich A Stephan
Journal:  Neurodegener Dis       Date:  2007-11-01       Impact factor: 2.977

5.  A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity.

Authors:  Priyamvada Rajasethupathy; Igor Antonov; Robert Sheridan; Sebastian Frey; Chris Sander; Thomas Tuschl; Eric R Kandel
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

6.  Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.

Authors:  Sebastian Treusch; Shusei Hamamichi; Jessica L Goodman; Kent E S Matlack; Chee Yeun Chung; Valeriya Baru; Joshua M Shulman; Antonio Parrado; Brooke J Bevis; Julie S Valastyan; Haesun Han; Malin Lindhagen-Persson; Eric M Reiman; Denis A Evans; David A Bennett; Anders Olofsson; Philip L DeJager; Rudolph E Tanzi; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Science       Date:  2011-10-27       Impact factor: 47.728

7.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

8.  Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.

Authors:  Xinzhong Li; Jintao Long; Taigang He; Robert Belshaw; James Scott
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

9.  Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies.

Authors:  Eduardo Pérez-Palma; Bernabé I Bustos; Camilo F Villamán; Marcelo A Alarcón; Miguel E Avila; Giorgia D Ugarte; Ariel E Reyes; Carlos Opazo; Giancarlo V De Ferrari
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

Review 10.  Neighboring gene regulation by antisense long non-coding RNAs.

Authors:  Victoria E Villegas; Peter G Zaphiropoulos
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

View more
  4 in total

1.  Quantitative Trait Module-Based Genetic Analysis of Alzheimer's Disease.

Authors:  Shaoxun Yuan; Haitao Li; Jianming Xie; Xiao Sun
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

2.  Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.

Authors:  Qingling Sun; Jingnian Ni; Mingqing Wei; Siwei Long; Ting Li; Dongsheng Fan; Tao Lu; Jing Shi; Jinzhou Tian
Journal:  Front Aging Neurosci       Date:  2022-08-18       Impact factor: 5.702

3.  Transcriptome-wide piRNA profiling in human brains for aging genetic factors.

Authors:  Qiao Mao; Longhua Fan; Xiaoping Wang; Xiandong Lin; Yuping Cao; Chengchou Zheng; Yong Zhang; Huihao Zhang; Rolando Garcia-Milian; Longli Kang; Jing Shi; Ting Yu; Kesheng Wang; Lingjun Zuo; Chiang-Shan R Li; Xiaoyun Guo; Xingguang Luo
Journal:  Jacobs J Genet       Date:  2019-08-20

4.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.